Product Images Lovenox

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 32 images provide visual information about the product associated with Lovenox NDC 0075-0623 by Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure A - lovenox 01

Figure A - lovenox 01

Figure B - lovenox 02

Figure B - lovenox 02

Figure C - lovenox 03

Figure C - lovenox 03

Figure D - lovenox 04

Figure D - lovenox 04

Figure E - lovenox 05

Figure E - lovenox 05

Chemical Structure - lovenox 06

Chemical Structure - lovenox 06

Chemical Structure - lovenox 07

Chemical Structure - lovenox 07

Figure 1 - lovenox 08

Figure 1 - lovenox 08

This appears to be a table with various subgroups of patients in a study, along with the number of patents in each subgroup and their characteristics such as age, gender, diabetes status, fibrinolytic agent used, and time of treatment. The last row may represent the total number of patients in the study.*

Figure 2 - lovenox 09

Figure 2 - lovenox 09

PRINCIPAL DISPLAY PANEL - 30 mg/0.3 mL Syringe Carton - lovenox 10

PRINCIPAL DISPLAY PANEL - 30 mg/0.3 mL Syringe Carton - lovenox 10

PRINCIPAL DISPLAY PANEL - 40 mg/0.4 mL Syringe Carton - lovenox 11

PRINCIPAL DISPLAY PANEL - 40 mg/0.4 mL Syringe Carton - lovenox 11

PRINCIPAL DISPLAY PANEL - 60 mg/0.6 mL Syringe Carton - lovenox 12

PRINCIPAL DISPLAY PANEL - 60 mg/0.6 mL Syringe Carton - lovenox 12

PRINCIPAL DISPLAY PANEL - 80 mg/0.8 mL Syringe Carton - lovenox 13

PRINCIPAL DISPLAY PANEL - 80 mg/0.8 mL Syringe Carton - lovenox 13

PRINCIPAL DISPLAY PANEL - 100 mg/1 mL Syringe Carton - lovenox 14

PRINCIPAL DISPLAY PANEL - 100 mg/1 mL Syringe Carton - lovenox 14

PRINCIPAL DISPLAY PANEL - 300 mg/3 mL Vial Carton - lovenox 15

PRINCIPAL DISPLAY PANEL - 300 mg/3 mL Vial Carton - lovenox 15

PRINCIPAL DISPLAY PANEL - 120 mg/0.8 mL Syringe Carton - lovenox 16

PRINCIPAL DISPLAY PANEL - 120 mg/0.8 mL Syringe Carton - lovenox 16

PRINCIPAL DISPLAY PANEL - 150 mg/1 mL Syringe Carton - lovenox 17

PRINCIPAL DISPLAY PANEL - 150 mg/1 mL Syringe Carton - lovenox 17

lovenox 18

lovenox 18

lovenox 19

lovenox 19

lovenox 20

lovenox 20

lovenox 21

lovenox 21

lovenox 22

lovenox 22

lovenox 23

lovenox 23

lovenox 24

lovenox 24

lovenox 25

lovenox 25

Lovenox® is a medication in the form of enoxaparin sodium injection that is derived from porcine intestinal mucosa. It is recommended to be used for subcutaneous injection with a dosage mentioned in the package insert. The medication is designed to be stored at 25°C (77°F) with permitted excursions to 15-30°C (59-86°F). It is a single-dose syringe equipped with an automatic safety device. There are no specific instructions provided for administration but they may be found in the package insert. The text also includes some additional information about the product's manufacturer, Sanofiaventis US, LLC.*

lovenox 26

lovenox 26

Lovenox® is a medication that contains 40mg of enoxaparin sodium derived from porcine intestinal mucosa in each syringe. It is intended for subcutaneous injection and the dosage information and directions are provided in the package insert. The syringes are equipped with an automatic safety device for subcutaneous injection. It is important to keep Lovenox® out of reach of children and to store it at 25°C (77°F). The text includes directions for using Lovenox® Single Dose syringes with automatic safety devices and a data matrix code.*

lovenox 27

lovenox 27

LOVENOX® is a medication available in single-dose syringes with automatic safety devices for subcutaneous injection. Each syringe includes 60mg of enoxaparin sodium injection extracted from porcine intestinal mucosa in water for injection. The dosage must be adjusted depending on the patient's condition, age, weight, and any other medication they are taking. Store the medication at room temperature, but avoid high excursions above 30°C or below 15°C. You must confirm the correct dose before injecting the medication subcutaneously. The instructions for use and dosage information are described in the package insert. Keep LOVENOX® out of reach of children.*

lovenox 28

lovenox 28

Lovenox® is a medication available in the form of single-dose syringes with an automatic safety device for subcutaneous injection. Each syringe contains 80mg of enoxaparin sodium injection derived from porcine intestinal mucosa in water for injection. The dosage and administration should be done by following the instructions provided in the package insert. It is important to keep the syringes out of reach of children and store them at controlled room temperature. The syringe's safety device can only be activated once the syringe is removed from the patient. The medicine is produced by Sanofi-aventis, and the area on the package is reserved for serialization.*

lovenox 29

lovenox 29

Lovenax® is a medication that is administered subcutaneously through injection. The main ingredient is enoxaparin sodium, which is derived from porcine intestinal mucosa. Each syringe of Lovenax contains 100mg of the substance. The package insert contains the information and dosage guidelines for use. The syringe features an automatic safety device. A single graduation on the syringe equals 25mg of enoxaparin sodium. The solution can be stored at a temperature of 25°C and with excursions permitted up to 15-30°C. The medication must be kept out of reach of children. The prescription drug is intended for a single-use only. The text also includes a warning and company information.*

lovenox 30

lovenox 30

LOVENOX® is an injectable medication containing 10mg of enoxaparin sodium derived from porcine intestinal mucosa and 1.5mg of benzyl alcohol. It is used for subcutaneous or intravenous injection, and dosage information can be found in the package insert. LOVENOX® should be kept out of reach of children and stored between 15-30°C (59-86°F). Multiple dose vials should not be stored for more than 28 days after the first use.*

lovenox 31

lovenox 31

Lovenox is a drug that contains 120mg of enoxaparin sodium injection derived from porcine intestinal mucosa in Water for Injection. It is administered for subcutaneous injection using a single-dose syringe with an automatic safety device. Each 0.02mL graduation equals 3mg of enoxaparin sodium injection. There are ten 0.8mL syringes in a packet, and dosage information and directions for use can be found in the package insert. Keep Lovenox out of reach of children and store at a temperature between 15-30°C (59-86°F). The activation of the safety system may cause minimal splatter, and the syringe should be immediately disposed of in a sharps container.*

lovenox 32

lovenox 32

Lovenox is a medication that contains 150mg of enoxaparin sodium injection derived from porcine intestinal mucosa. It is used for subcutaneous injection and comes in single-dose syringes with an automatic safety device. The dosage information and directions can be found in the package insert. Lovenox should be stored at 25°C and kept out of reach of children. The text includes a warning to dispose of the syringe in a sharps container after use. The rest of the text is illegible or contains non-English characters.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.